Date | Time | Source | Headline | Symbol | Company |
09/05/2024 | 4:05PM | GlobeNewswire Inc. | Harvard Bioscience, Inc. to Participate in the Sidoti Small Cap Virtual Conference | NASDAQ:HBIO | Harvard Bioscience Inc |
08/08/2024 | 9:00AM | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] | NASDAQ:HBIO | Harvard Bioscience Inc |
08/08/2024 | 8:30AM | GlobeNewswire Inc. | Harvard Bioscience Announces Second Quarter 2024 Financial Results | NASDAQ:HBIO | Harvard Bioscience Inc |
08/08/2024 | 8:29AM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:HBIO | Harvard Bioscience Inc |
08/02/2024 | 8:00AM | GlobeNewswire Inc. | Harvard Bioscience Schedules Second Quarter 2024 Earnings Conference Call for August 8, 2024 at 10:00 AM ET | NASDAQ:HBIO | Harvard Bioscience Inc |
06/14/2024 | 4:02PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:HBIO | Harvard Bioscience Inc |
06/07/2024 | 4:02PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:HBIO | Harvard Bioscience Inc |
06/06/2024 | 4:05PM | GlobeNewswire Inc. | Harvard Bioscience, Inc. to Present and Host One-on-One Meetings at the 14th Annual East Coast IDEAS Conference on June 12, 2024 | NASDAQ:HBIO | Harvard Bioscience Inc |
05/29/2024 | 5:01PM | Edgar (US Regulatory) | Form SD - Specialized disclosure report | NASDAQ:HBIO | Harvard Bioscience Inc |
05/23/2024 | 4:24PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:HBIO | Harvard Bioscience Inc |
05/23/2024 | 4:23PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:HBIO | Harvard Bioscience Inc |
05/23/2024 | 4:22PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:HBIO | Harvard Bioscience Inc |
05/23/2024 | 4:05PM | GlobeNewswire Inc. | Harvard Bioscience, Inc. to Present at the Jefferies Global Healthcare Conference on June 5, 2024 | NASDAQ:HBIO | Harvard Bioscience Inc |
05/16/2024 | 4:05PM | GlobeNewswire Inc. | Harvard Bioscience, Inc. to Participate in the Benchmark Healthcare House Call Virtual Conference | NASDAQ:HBIO | Harvard Bioscience Inc |
05/14/2024 | 5:20PM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:HBIO | Harvard Bioscience Inc |
05/07/2024 | 5:00PM | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] | NASDAQ:HBIO | Harvard Bioscience Inc |
05/07/2024 | 7:00AM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:HBIO | Harvard Bioscience Inc |
05/07/2024 | 7:00AM | GlobeNewswire Inc. | Harvard Bioscience Announces First Quarter 2024 Financial Results | NASDAQ:HBIO | Harvard Bioscience Inc |
04/29/2024 | 8:45AM | GlobeNewswire Inc. | Harvard Bioscience Schedules First Quarter 2024 Earnings Conference Call for May 7, 2024 at 8:00 AM ET | NASDAQ:HBIO | Harvard Bioscience Inc |
04/09/2024 | 9:00AM | GlobeNewswire Inc. | Harvard Bioscience Announces Action to Improve Operational Efficiency and Support Ongoing Investments in Growth | NASDAQ:HBIO | Harvard Bioscience Inc |
03/11/2024 | 8:00AM | GlobeNewswire Inc. | Harvard Bioscience, Inc. to Participate in March 2024 Investor Conferences: Sidoti’s Small Cap Conference and KeyBanc’s Life Sciences & MedTech Conference | NASDAQ:HBIO | Harvard Bioscience Inc |
03/07/2024 | 5:00PM | Edgar (US Regulatory) | Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] | NASDAQ:HBIO | Harvard Bioscience Inc |
03/07/2024 | 4:04PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:HBIO | Harvard Bioscience Inc |
03/07/2024 | 4:03PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:HBIO | Harvard Bioscience Inc |
03/07/2024 | 7:00AM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:HBIO | Harvard Bioscience Inc |
03/07/2024 | 7:00AM | GlobeNewswire Inc. | Harvard Bioscience Announces Fourth Quarter 2023 Financial Results | NASDAQ:HBIO | Harvard Bioscience Inc |
03/06/2024 | 8:30AM | GlobeNewswire Inc. | Harvard Bioscience to Showcase Latest Solutions for Preclinical and Organoid Applications at Society of Toxicology Meeting | NASDAQ:HBIO | Harvard Bioscience Inc |
02/27/2024 | 5:10PM | GlobeNewswire Inc. | Harvard Bioscience Schedules Fourth Quarter 2023 Earnings Conference Call for March 7, 2024 at 8:00 AM ET | NASDAQ:HBIO | Harvard Bioscience Inc |
02/14/2024 | 4:05PM | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] | NASDAQ:HBIO | Harvard Bioscience Inc |
02/14/2024 | 9:00AM | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] | NASDAQ:HBIO | Harvard Bioscience Inc |